[1] 贺红杰,宋磊,赵丹懿,等.雷替曲塞联合奥沙利铂经TACE治疗不可切除肝癌患者的疗效评价[J].介入放射学杂志,2016,25(1):40-43. [2] 赖林,侯恩存,陆运鑫,等.奥沙利铂一线治疗后再引入与雷替曲塞联合二线治疗晚期结直肠癌的临床观察[J].中国肿瘤临床,2016,43(5):188-193. [3] Honjo M.Relationship between the liver tissue shear modulus and histopathologic findings analyzed by intraoperative shear wave elastography and digital microscopically assisted morphometry in patients with hepatocellular carcinoma[J].J Ultrasound Med,2014,33(1):61-71. [4] Dunne RM,Shyn PB,Sung JC,et al.Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: A comparison of the safety of cryoablation and radiofrequency ablation[J].Eur J Radiol,2014,83(4):632-638. [5] 姚玮,张君儒,陈连锁,等.雷替曲塞TACE治疗胃癌术后肝转移的近期疗效观察[J].介入放射学杂志,2016,25(2):125-128. [6] 于志红,张娟.雷替曲塞联合西妥昔单抗治疗K-ras野生型转移性结直肠癌的临床疗效及与EGFR蛋白表达状态的相关性[J].中国老年学杂志,2018,38(20):4886-4889. [7] Hui Liu,Han Wang,Yanhong Xu,et al.Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma[J].ACS Appl Mater Interfaces,2014,6(9):6944-6953. [8] Huang S,Yu J,Liang P,et al.Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: A long-term follow-up[J].Eur J Radiol,2014,83(3):552-558. [9] 张鑫,朱林忠,朱旭,等.雷替曲塞持续动脉灌注化疗的药代动力学研究[J].中国实验诊断学,2016,13(1):8-11. [10] Choi JI,Jung SE,Kim PN,et al.Quality assurance in ultrasound screening for hepatocellular carcinoma using a standardized phantom and standard clinical images: A 3-year national investigation in Korea[J].J Ultrasound Med,2014,33(6):985-995.
2020, Vol. 37 
